← Leaderboards
Michel Ledizet
L2 Diagnostics, Llc
$12,357,647
Attributed
$12,757,647
Total exposure
17
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.3M · FY2006–25$2.5M$1.9M$1.3M$625K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,757,647 · 17
By mechanism
R44$7,122,120 · 4
R41$2,765,527 · 4
R43$2,570,000 · 8
N01$300,000 · 1
Top collaborators
- Albert Icksang Ko2 shared
- Utpal Pal2 shared
Others in their field
Top investigators on “Infection”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,939,185
- Lawrence Corey · Fred Hutchinson Cancer Center$789,608,171
- Judith S. Currier · University Of California Los Angeles$511,038,212
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$463,711,983
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$415,229,497
Research focus
InfectionBaseLyme DiseaseSerumRecombinant ProteinsAntigensDiagnosisProteinsTicksAntibodiesAntibioticsCenters For Disease Control And Prevention (U.S.)ResponseSamplingUnited StatesPathogenEnzyme-Linked Immunosorbent AssayAnimalsSymptomsOrder SpirochaetalesResearch StudySensitivity And SpecificityMedicalBlood
Grant awards (29)
NOVEL DIAGNOSTIC BIOMARKERS DISCOVERY AND VALIDATION FOR MALARIA$300,000
N01 · FY2025 · AI · contact PI
An antigen-detection assay to diagnose Babesia microti infection$692,082
R44 · FY2022 · AI · contact PI
An antigen-detection assay to diagnose Babesia microti infection$692,082
R44 · FY2021 · AI · contact PI
Vaccination against Zika virus infection using mosquito NeSt1 protein$293,886
R41 · FY2021 · AI · contact PI
An antigen-detection assay to diagnose Babesia microti infection$692,082
R44 · FY2020 · AI · contact PI
Vaccination against Zika virus infection using mosquito NeSt1 protein$299,200
R41 · FY2020 · AI · contact PI
An antigen-detection assay to diagnose Babesia microti infection$299,975
R43 · FY2018 · AI · contact PI
Validation of a Diagnostic Test for Borrelia miyamotoi$274,312
R41 · FY2018 · AI · contact PI
Validation of a Diagnostic Test for Borrelia miyamotoi$299,905
R41 · FY2017 · AI · contact PI
A serologic assay to measure successful Lyme borreliosis antibiotic therapy$879,662
R44 · FY2016 · AI · contact PI
A serologic assay to measure successful Lyme borreliosis antibiotic therapy$879,662
R44 · FY2015 · AI · contact PI
Diagnostic Assays for early Lyme Borreliosis using in-vivo expressed antigens$825,690
R44 · FY2015 · AI · contact PI
RNA Detection as an Improved Diagnostic Assay for Human Leptospirosis$300,000
R41 · FY2015 · AI · contact PI
A serologic assay to measure successful Lyme borreliosis antibiotic therapy$883,404
R44 · FY2014 · AI · contact PI
Diagnostic Assays for early Lyme Borreliosis using in-vivo expressed antigens$829,432
R44 · FY2014 · AI · contact PI
RNA Detection as an Improved Diagnostic Assay for Human Leptospirosis$300,000
R41 · FY2014 · AI · contact PI
A Lyme disease vaccine using newly identified in-vivo expressed antigens$295,725
R43 · FY2014 · AI · contact PI
A Lyme disease vaccine using newly identified in-vivo expressed antigens$299,681
R43 · FY2013 · AI · contact PI
Diagnostic Assays for early Lyme Borreliosis using in-vivo expressed antigens$290,340
R43 · FY2012 · AI · contact PI
A serologic assay to measure successful Lyme borreliosis antibiotic therapy$278,455
R43 · FY2010 · AI · contact PI
Nanoparticle-based vaccines against flaviviruses$300,000
R43 · FY2009 · AI · contact PI
Nanoparticle-based vaccines against flaviviruses$291,408
R43 · FY2008 · AI · contact PI
Lyme Disease Diagnostics Using In Vivo Expressed Borrelia Burgdorferi Antigens$275,834
R43 · FY2008 · AI · contact PI
Antivirals Targeting Flavivirus Envelope Proteins$504,551
R41 · FY2007 · AI · contact PI
Antivirals Targeting Flavivirus Envelope Proteins$493,673
R41 · FY2006 · AI · contact PI
Vaccination Against Ixodes scapularis Tick Bites$373,830
R44 · FY2003 · AI
A Novel Family of Anticoagulants from Ixodes scapularis$138,854
R43 · FY2003 · HL
Therapeutic Activity of a Novel Tick Immunosuppressant$99,728
R43 · FY2003 · AI
Vaccination Against Ixodes scapularis Tick Bites$374,194
R44 · FY2002 · AI